Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Ultratech Announces First Quarter 2007 Results

Abstract:
Ultratech, Inc. (Nasdaq:UTEK) today announced unaudited results for the three-month period ended March 31, 2007.

Ultratech Announces First Quarter 2007 Results

SAN JOSE, CA | Posted on April 19th, 2007

For the first quarter of fiscal 2007, Ultratech reported net sales of $27.4 million compared to $34.9 million during the first quarter of 2006. Ultratech's net loss for the first quarter of 2007 was $3.2 million or $0.14 per share compared to a net profit of $1.6 million or $0.06 per share (diluted) for the same quarter last year.

Arthur W. Zafiropoulo, Ultratech Chairman and Chief Executive Officer, stated, "At the end of 2006, we recognized the need to resize our company in response to changing market conditions. Since that decision was made, Ultratech has continued to make headway operationally and I am pleased with our plan execution during the quarter. Most notably, during the quarter, we recognized revenue for two LSA100 tools, improved gross margins by decreasing manufacturing and logistics costs, reduced inventories and increased cash."

"Although the business environment of the semiconductor industry continues to be uncertain, our strategy to drive operational efficiencies on a global scale remains unchanged. Ultratech continues to aggressively manage our operating expenses while maintaining our commitment to create long-term growth and value for our stockholders. We believe that these strategies are designed to enhance our operating performance through the course of this year and in following years," Zafiropoulo concluded.

At March 31, 2007, Ultratech had $129 million in cash, cash equivalents, short-term and long-term investments. Working capital was $112 million and stockholders' equity was $7.39 per share based on 23,251,782 total shares outstanding on March 31, 2007.

Conference Call Information

The conference call will be broadcast live over the Internet beginning at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time on Thursday, April 19, 2007. To listen to the call over the Internet or to obtain telephone dial-in information for the call, please go to Ultratech's web site at www.ultratech.com.

If you are unable to attend the live conference call, a replay will be available on Ultratech's web site. If you do not have Internet access, a replay of the call will be available three hours after the conclusion of the call and run until 9:00 p.m. Pacific Time, April 21, 2007. You may access the telephone replay by dialing 888-203-1112 for domestic callers, 719-457-0820 for international callers and entering access code: 9014754.

####

About Ultratech, Inc.
Ultratech, Inc. (NasdaqGM:UTEK) designs, manufactures and markets photolithography equipment used worldwide in the fabrication of semiconductor and nanotechnology devices, and has expanded its technology scope in pioneering laser processing technology for IC manufacturing. Founded in 1979, Ultratech is a market leader in gold and solder bump lithography. Its products are designed to substantially reduce the cost of ownership for manufacturers in the electronics industry. The company's home page on the World Wide Web is located at http://www.ultratech.com .

Certain of the statements contained herein, which are not historical facts and which can generally be identified by words such as “anticipates,” “expects,” “intends,” “will,” “could,” “believes,” “estimates,” “continue,” and similar expressions, are forward-looking statements under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties, such as risks related to integration of Oraxion’s technology and products with our technology and products and market acceptance thereof; our dependence on new product introductions and market acceptance of new products and enhanced versions of our existing products; lengthy sales cycles, including the timing of system installations and acceptances; lengthy and costly development cycles for laser-processing and lithography technologies and applications; integration, development and associated expenses of the laser processing operation; delays, deferrals and cancellations of orders by customers; cyclicality in the semiconductor and nanotechnology industries; pricing pressures and product discounts; high degree of industry competition; intellectual property matters; expiration of licensing arrangements, and the resulting adverse impact on our licensing revenues; changes to financial accounting standards; changes in pricing by us, our competitors or suppliers; customer concentration; international sales; timing of new product announcements and releases by us or our competitors; ability to volume produce systems and meet customer requirements; sole or limited sources of supply; ability and resulting costs to attract or retain sufficient personnel to achieve our targets for a particular period; dilutive effect of employee stock option grants on net income per share, which is largely dependent upon us achieving and maintaining profitability and the market price of our stock; mix of products sold; rapid technological change and the importance of timely product introductions; outcome of litigation; changes in accounting policies or interpretations of such policies; manufacturing variances and production levels; timing and degree of success of technologies licensed to outside parties; product concentration and lack of product revenue diversification; inventory obsolescence; asset impairment; effects of certain anti-takeover provisions; future acquisitions; volatility of stock price; foreign government regulations and restrictions and the exporting of sensitive technologies and jobs to certain countries; business interruptions due to natural disasters or utility failures; environmental regulations; and any adverse effects of terrorist attacks in the United States or elsewhere, or government responses thereto, or military actions in Iraq, Afghanistan and elsewhere, on the economy, in general, or on our business in particular. Such risks and uncertainties are described in Ultratech’s SEC reports including its Annual Report on Form 10-K filed for the year ended December 31, 2006. Due to these and additional factors, the statements, historical results and percentage relationships set forth herein are not necessarily indicative of the results of operations for any future period. These forward-looking statements are based on management’s current beliefs and expectations, some or all of which may prove to be inaccurate, and which may change. We undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.

ULTRATECH, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
 
(In thousands )   Mar. 31,
2007
 

Dec. 31,
2006*

ASSETS (Unaudited)
 

Current assets:

Cash, cash equivalents, and short-term investments

$90,228  $78,090 
Accounts receivable 26,599  18,054 
Inventories 38,291  40,988 

Prepaid expenses and other current assets

  3,038    2,181 
Total current assets 158,156  139,313 
 
Long-term investments 38,289  48,328 
 

Equipment and leasehold improvements, net

21,055  20,368 
 
Demonstration inventories, net 4,524  4,717 
 
Other assets   2,500    3,324 
 
Total assets   $224,524    $216,050 
 
         
LIABILITIES AND STOCKHOLDERS' EQUITY
 

Current liabilities:

Notes payable $16,278  $6,974 
Accounts payable

9,647 

10,440 
Deferred product and service income 4,518  2,950 
Other current liabilities   15,454    13,998 
Total current liabilities 45,897  34,362 
 
Other liabilities 6,855  7,579 
 
Stockholders' equity   171,772    174,109 
 
Total liabilities and stockholders' equity   $224,524    $216,050 
 

* The balance sheet as of December 31, 2006 has been derived from the audited financial statements as of that date.

ULTRATECH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
 

Three Months Ended

(In thousands, except per share amounts)   Mar. 31,
2007
  Apr. 1,
2006

Total net sales*

$27,368  $34,944 
 

Cost of sales:

Cost of products sold 14,460  19,116 
Cost of services  

2,108 

  2,171 
Total cost of sales   16,568    21,287 
Gross profit 10,800  13,657 

Operating expenses:

Research, development, and engineering

5,964  6,153 

Selling, general, and administrative

  9,302    7,297 
Operating income (loss) (4,466) 207 
Interest expense (333) (12)
Interest and other income, net   1,669    1,517 
 
Income (loss) before tax (3,130) 1,712 
Income taxes   115    130 
Net income (loss)   ($3,245)   $1,582 

Earnings per share - basic:

Net income (loss) ($0.14) $0.07 
Number of shares used in per share calculations - basic 23,285  23,830 

Earnings per share - diluted:

Net income (loss) ($0.14) $0.06 
Number of shares used in per share calculations - diluted   23,285    25,127 

* Systems Sales

$18,806  $26,873 
Parts Sales 4,701  4,536 
Service Sales   3,861    3,535 
Total Sales   $27,368    $34,944 

UTEK-F

For more information, please click here

Contacts:
Ultratech, Inc.
Bruce Wright, 408-321-8835
Sr. Vice President, Finance/CFO
or
Laura Rebouché, 408-321-8835
Vice President of Investor Relations
and Corporate Communications

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Chip Technology

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

Progress made in developing nanoscale electronics: New research directs charges through single molecules April 21st, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Scientists open door to better solar cells, superconductors and hard-drives: Research enhances understanding of materials interfaces April 14th, 2014

Announcements

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Financial Reports

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014

Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014

Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE